DC Vaccine in Pancreatic Cancer
NCT03592888
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Ductal Adenocarcinoma
Interventions
DRUG:
mDC3/8-KRAS Vaccine
Sponsor
University of Pennsylvania